Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Cerecor announces research grant for the development of CERC-501

July 27, 2016

Cerecor awarded grant from NIAAA

July 21, 2016

Addex Therapeutics reports positive results on ADX-71441

June 10, 2016

FDA awards fast track designation to Indivior's RBP-6000 buprenorphine monthly depot

May 27, 2016

FDA approves Probuphine for opioid dependence

May 27, 2016

Cerecor awarded NIDA grant

April 12, 2016

XT-150 as a potential solution for opioid abuse crisis

April 4, 2016

Cleveland BioLabs updates progress of entolimod pre-EUA review

March 17, 2016

Narcan now available in U.S. for the treatment of opioid overdose

Feb. 26, 2016

FDA lifts clinical hold on Aeolus's AEOL-10150 in acute radiation syndrome

Feb. 23, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...